Wei Chao Huang
About Wei Chao Huang
Wei Chao Huang is a Postdoctoral Associate at the Broad Institute of MIT and Harvard, with a background in neuroscience and extensive experience in research and analysis of next-generation sequencing data. He has held various academic and research positions, including roles at Amgen and the University of Utah, and has published seven first-authored papers in his field.
Current Role at Broad Institute
Wei Chao Huang currently serves as a Postdoctoral Associate at the Broad Institute of MIT and Harvard. He has held this position since 2021, contributing to research initiatives in Cambridge, Massachusetts. His work focuses on advancing the understanding of epigenetic studies and disease diagnosis through statistical frameworks.
Previous Experience at Amgen
Prior to his current role, Wei Chao Huang worked as a Postdoctoral Fellow at Amgen from 2019 to 2021. During his tenure in the Greater Boston Area, he engaged in research that enhanced his expertise in next-generation sequencing data analysis.
Educational Background
Wei Chao Huang holds a Doctor of Philosophy (Ph.D.) in Neurobiology and Anatomy from the University of Utah, where he studied from 1999 to 2004. He also earned a Master's degree in Neuroscience from National Yang Ming University between 2004 and 2007. His Bachelor's degree in Occupational Therapy, with a minor in Genomic Medicine Program, was obtained from National Taiwan University from 2010 to 2016.
Research and Technical Skills
Wei Chao Huang has developed statistical frameworks for analyzing next-generation sequencing (NGS) data using R and Python. He possesses extensive experience in tissue and stem cell culture, as well as molecular and cell biology techniques, including PCR/qPCR, microscopy, immunostaining, and various blotting techniques. He is also skilled in mouse behavioral tests.
Professional Certifications and Licenses
Wei Chao Huang is a licensed occupational therapist in Taiwan. He has also obtained several finance certificates in Taiwan and successfully passed the level 1 CFA program exam, showcasing his diverse skill set beyond his scientific expertise.